Ternary Copper(II) Complexes With Indomethacin, a PotentNon‐Steroidal Antiinflammatory Drug. Crystal Structure of Bis(Dimethylformamide)‐Tetrakis[1‐(4‐Chlorobenzoyl)‐5‐Methoxy‐2‐Methyl‐1‐<i>H</i>‐Indole‐3‐Acetato]Dicopper(II).Antiinflammatory Properties andPrevention of Gastrointestinal Side Effects by Nanocapsules

Fadila Guessous, Jean‐Claude Daran, Georges Morgant, X. Labouze, Anne Laure Leroy, M Roch-Arveiller, Dung Nguyen‐Huy

Metal-Based Drugs · 1998 · 11 citations · 2 references

DOIFull text

Open access

Concepts

Abstract

Two ternary copper(ll) complexes of indomethacin [1-(4-chlorobenzoyl)-5-methoxy-2- methyl-1-H-indole-3-acetic acid] called hereafter lndo, were prepared and characterized by single crystal X-ray diffraction. The first complex Cu(2)(Indo)(4)(DMF)(2) I crystallizes in space group P-1 (a = 10.829(2), b = 13.379(2), c = 16.491(3) A; alpha = 105.58(2), beta = 101.06(2), gamma = 106.96(2) degrees ; V= 2104.6(6) A(3), Z= 1). The title molecule is a centrosymmetric binuclear complex, with Cu atoms bridged by the carboxylate moieties of four indomethacinate ligands. The four nearest O atoms around each Cu atom form a square planar arrangement with the square pyramidal coordination completed by the O atom of N,N'-dimethylformamide. Daily administration for seven days of 1 mg/kg of indomethacin, I and I encapsulated into liposomes induces a weak inflammation of rat gastrointestinal tract. I was less inflammatory than indomethacin but the better protection was brought by encapsulation of the compound. This might be of interest in sustained therapies of chronic inflammatory diseases.

References

2